相关实验视频
Updated: Jun 28, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
87
纤维化在炎症性类风湿性疾病中的潜在治疗点
Jiang Su1, Julianna Desmarais2, Cong-Qiu Chu3
1Department of Rheumatology and Immunology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Best practice & research. Clinical rheumatology
|April 16, 2024
概括
风湿性疾病中常见的纤维化,带来了治疗挑战. 新的研究突出介绍了Interleukin-11和纤维细胞激活蛋白 (FAP) 作为抗纤维菌疗法的有前途的治疗点.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
背景情况:
- 纤维化是慢性风湿性疾病的严重并发症,导致严重疾病和死亡.
- 目前的抗纤维素治疗方法不足以阻止疾病的进展,特别是肺纤维化.
- 对于管理纤维状况的新型治疗策略有着至关重要的需求.
研究的目的:
- 审查最近关于治疗纤维化治疗的治疗点的发现.
- 探索介质蛋白-11和纤维细胞激活蛋白 (FAP) 作为抗纤维菌疗法的点的潜力.
主要方法:
- 关于纤维瘤疾病和潜在治疗点的最新研究的文献综述.
- 分析了Interleukin-11作为纤维化细胞因子的作用.
- 检查纤维细胞激活蛋白 (FAP) 表达和向策略.
主要成果:
- 互乐金-11被确定为一种关键的纤维化细胞因子,易受单克隆抗体的阻断.
- 纤维细胞激活蛋白 (FAP) 在纤维组织中的激活纤维细胞上高度表达.
- 针对癌症治疗中探索的FAP,显示了治疗风湿性疾病纤维化的潜力.
结论:
- 介素-11和FAP代表了纤维化的新兴和可行的治疗点.
- 针对这些途径可能为治疗风湿性疾病和肺纤维化中的纤维化提供新的途径.
- 对FAP向模式的进一步研究可能会转化为有效的抗纤维菌治疗.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
136
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
136
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Introduction to Fibroblasts
3.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127

